Craig Eagle - 01 Jul 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Reporting relationship: Chief Medical Officer
Issuer ticker: GH
Reported as of: 01 Jul 2025
Net transaction value: -$86,917
SEC form: 4
Accepted by SEC: 02 Jul 2025, 21:22:50 UTC
Prior SEC filing: 16 Jun 2025
Next SEC filing: 17 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ John G. Saia, as attorney-in-fact for Craig Eagle

Key filing fact

Craig Eagle filed Form 4 for Guardant Health, Inc. (GH) on 02 Jul 2025.

Key facts

This page summarizes Craig Eagle's Form 4 filing for Guardant Health, Inc. (GH).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Jul 2025, 21:22.

Change

Previous filing in this sequence was filed on 16 Jun 2025.
Current net transaction value: -$86,917.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001562135 Primary reporting owner

EAGLE CRAIG

Relationship: Chief Medical Officer
Address: 3100 HANOVER STREET, PALO ALTO
Signature: /s/ John G. Saia, as attorney-in-fact for Craig Eagle
Signature date: 02 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,714
Change %: +4.9%
Price: $0.000000
Shares after: 36,838
Date: 01 Jul 2025
Ownership: Direct

GH transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,667
Change %: +4.5%
Price: $0.000000
Shares after: 38,505
Date: 01 Jul 2025
Ownership: Direct

GH transaction

Common Stock

Tax liability

Transaction value: $86,917
Shares: -1,714
Change %: -4.5%
Price: $50.71
Shares after: 36,791
Date: 01 Jul 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,714
Change %: -17%
Price: $0.000000
Shares after: 8,571
Date: 01 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,714
Exercise price: $0.000000
Footnotes: F2, F3

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,667
Change %: -17%
Price: $0.000000
Shares after: 8,337
Date: 01 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,667
Exercise price: $0.000000
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Footnote F2

This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

Footnote F3

Not applicable for Restricted Stock Units.

Footnote F4

This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.